In fact, LVMI differed significantly across the FGF23 tertiles among patients with CKD stages G1/G2 (P = 0.002, by Kruskal-Wallis analysis), G3a (P = 0.013), and G4/G5 (P = 0.035). This evidence concerns the gene FGF23 and chronic kidney disease.